Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Phase 2 Trial

Recent news which mentions Phase 2 Trial

< Previous 1 2 3 4 5 6 7 8 9 Next >
BiomX's Acne Vulgaris Treatment Fails To Top Vehicle Treatment Cohort
Tickers PHGE
Tags Health Care Biotech Trading Ideas
From Benzinga
Vertex Unveils First Patient Results On Potential Diabetes Treatment
Tickers VRTX
Tags VRTX Benzinga Phase 2 Trial
From Benzinga
Regenxbio Reveals Interim Data From Diabetic Retinopathy Gene Therapy Trial
Tickers RGNX
Tags Small Cap Biotech gene therapy
From Benzinga
Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study
Tickers BMY
Tags Briefs News Movers
From Benzinga
Denali Highlights Encouraging Early Data, Update For Amyotrophic Lateral Sclerosis Program
Tickers DNLI SNY
Tags SNY News Briefs
From Benzinga
Entera Bio's Formulated Human Parathyroid Hormone Shows Encouraging BMD Data
Tickers ENTX
Tags Biotech ENTX Health Care
From Benzinga
Vaxart Starts Recruitment In Mid-Stage COVID-19 Oral Vaccine Trial
Tickers VXRT
Tags COVID/19 Coronavirus General Briefs
From Benzinga
Takeda Discontinues Two Mid-Stage Narcolepsy Trials
Tickers TAK TKPHF
Tags Biotech Briefs News
From Benzinga
Why Did Kaleido Shares Plunge 10% On Tuesday?
Tickers KLDO
Tags General Movers Briefs
From Benzinga
Gemini Axes Chief Scientific Officer, 20% Of Staff To Focus On Geographic Atrophy Candidate
Tickers GMTX
Tags Phase 2 Trial Market News Benzinga
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
Tickers ANVS
Tags Exclusives General Briefs
From Benzinga
Why Did RedHill Biopharma Shares Jump 12% Monday?
Tickers RDHL
Tags COVID/19 Coronavirus General Phase 3 Trial
From Benzinga
Enanta To Discontinue Internal Development Of NASH Candidates
Tickers ENTA
Tags Briefs News Movers
From Benzinga
AnaptysBio Reveals Updated Imsidolimab Data In Severe Form Of Psoriasis
Tickers ANAB
Tags Briefs News ANAB
From Benzinga
CTI BioPharma's COVID-19 Candidate Misses Primary Endpoint Mark In Phase 2 Trial
Tickers CTIC
Tags COVID/19 Coronavirus General News
From Benzinga
Xenon Pharma Shares Jump After Epilepsy Treatment Phase 2 Data Meets Primary Endpoint
Tickers XENE
Tags Health Care epilepsy Biotech
From Benzinga
J&J's RSV Vaccine Candidate Shows 80% Efficacy In Older Adults
Tickers JNJ
Tags Market News JNJ Phase 2 Trial
From Benzinga
Eli Lilly's Mirikizumab Maintains Symptomatic Remission for Two Years In Ulcerative Colitis Patients
Tickers LLY
Tags News Briefs Biotech
From Benzinga
Precigen Posts Additional Interim Data From Type 1 Diabetes Trial
Tickers PGEN PRVB
Tags Phase 1 Trial Biotech Type I Diabetes
From Benzinga
BioNTech Starts Dosing In Mid-Stage Colorectal Cancer Immunotherapy Trial
Tickers BNTX RHHBF RHHBY RHHVF
Tags RHHVF RHHBF Movers
From Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
Tickers NERV
Tags General Phase 3 Trial Movers
From Benzinga
AIM ImmunoTech Recruits hVIVO For Ampligen Trial For Prophylaxis Use Against Respiratory Viruses
Tickers AIM
Tags General Health Care Biotech
From Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags RHHVF RHHBF Briefs
From Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
Tickers EDIT
Tags Trading Ideas Benzinga Market News
From Benzinga
Adagio's COVID-19 Candidate Shows Prolonged Half-Life, Neutralization At Six Months
Tickers ADGI AZN AZNCF MRNA
Tags AZN Biotech MRNA
From Benzinga
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
Tickers GRAY REGN
Tags Briefs News Biotech
From Benzinga
Why Are I-Mab Shares Trading Higher On Tuesday?
Tickers IMAB MGNX MRK
Tags Benzinga Trading Ideas Phase 2 Trial
From Benzinga
Valneva, Pfizer Lyme Disease Vaccine Candidate Drops-Off After 18 Months
Tickers PFE VALN
Tags Phase 2 Trial Market News PFE
From Benzinga
Ultragenyx Resumes Dosing Antisense Trial In Rare Neurogenetic Disorder
Tickers RARE
Tags Angelman syndrome General Movers
From Benzinga
Pfizer Kick Starts Late-Stage Study For COVID-19 Oral Antiviral For Post-Exposure Prophylaxis
Tickers PFE
Tags Phase 3 Trial Health Care COVID/19 Coronavirus
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.